MAR 2025

Press Release

Senores Pharmaceuticals acquires 14 ANDAs from Dr. Reddy’s Laboratories

FEB 2025

Press Release

Senores Pharmaceuticals begins operations at greenfield API facility
Senores Pharmaceuticals acquires ANDA for Roflumilast 250 mcg and 500 mcg

JAN 2025

Press Release

Financial & Operational Performance for Q3 & 9MFY25
Senores Pharmaceuticals receives ANDA approval for marketing Metoprolol Tartrate and Hydrochlorothiazide Tablet

NOV 2024

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. launches Ivermectin Tablets in the U.S. market (Source: Nasdaq)
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. launches Ivermectin Tablets in the U.S. market (Source: Financial Times)

OCT 2024

Senores Pharmaceuticals gets SEBI's approval to float IPO (Source: Business Standard)

JUL 2024

Senores Pharmaceuticals files DRHP for IPO (Source: The Economic Times)

SEP 2023

Senores Pharmaceuticals, Inc. launches Nicardipine Hydrochloride Capsules (Source: BioSpace)

MAY 2022

Dr. Reddy's and Senores Pharmaceuticals, Inc. launches Ketorolac Tromethamine Tablets (Source: Business Standard)

MAR 2022

Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launches Butalbital, Acetaminophen and Caffeine Capsules (Source: TOI)

JAN 2022

Senores Pharmaceuticals, Inc. launches Mexiletine Hydrochloride Capsules (Source: Market Insider)

OCT 2021

Cintex Services, LLC and Senores Pharmaceuticals, Inc. launches Chlorzoxazone Tablets (Source: BioSpace)

NOV 2020

Jubilant Pharma Ltd. and Aavis Pharmaceuticals launches Hydroxychloroquine Sulfate Tablets (Source: Times of India)